type-1

Documents about type-1

• Insulin-based Strategies to Prevent Hypoglycemia During Exercise#28540ClinicalTrials.gov
• Flat and Circadian Insulin Infusion Rates in Continuous Subcutaneous Insulin Infusion#126009ClinicalTrials.gov
• A Trial of Three- and Seven-days Insulin Infusions Set#126042ClinicalTrials.gov
• GLP-1 and Non-exercise Activity Thermogenesis in RHZ#140950ClinicalTrials.gov
• FLuctuATion Reduction With inSULin and Glp-1 Added togetheR (FLAT-SUGAR)#140955ClinicalTrials.gov
• T1DM Immunotherapy Using CD4+CD127lo/-CD25+ Polyclonal Tregs#141165ClinicalTrials.gov
• Collection of Breath and Sweat to Identify Indicators of Hypoglycemia#141170ClinicalTrials.gov
• Anti-Thymocyte Globulin, Cyclosporine, and RAD in Islet Transplantation#148668ClinicalTrials.gov
• Bone Marrow as an Alternative Site for Islet Transplantation#148672ClinicalTrials.gov
• An Outpatient Pump Shutoff Pilot Feasibility and Safety Study#162393ClinicalTrials.gov
• Metformin Therapy in Type 1 Diabetes Mellitus.#208416ClinicalTrials.gov
• Safety Evaluation of MiniMed™ 780G System With DS5 CGM in Children#226198ClinicalTrials.gov
• Safety Evaluation of the Advanced Hybrid Closed Loop (AHCL) System#230351ClinicalTrials.gov
• Pilot Study to Verify Effect of Smartpen Coordinated With Glucose Sensor.#230352ClinicalTrials.gov
• Multiple Constrained MPCs for glucose regulation in Type 1 Diabetes#249195Zenodo (CERN)
• Liens entre diabète de type 2 et maladie de Parkinson#253998HAL (France)
• Matrix Metalloproteinases and Diabetic Nephropathy#261443ClinicalTrials.gov
• GWAS reveal SUBER GENE1-mediated suberization via type one phosphatases#268608HAL (France)
• Galactose - the Ideal Carbohydrate Supplement for Exercise in Type 1 Diabetes#283167ClinicalTrials.gov
• Sleep Patterns and Chronotype in Children With and Without Type 1 Diabetes#303647ClinicalTrials.gov
• Compliance to Vaccination in Children With Diabetes and Their Siblings#303684ClinicalTrials.gov
• Effect of CSII and CGM on Progression of Late Diabetic Complications#321612ClinicalTrials.gov
• Continuous Glucose Sensing at the Site of Subcutaneous Insulin Administration#325246ClinicalTrials.gov
• Fracture Risk After Pancreas Transplantation (FraPaT)#337092ClinicalTrials.gov
• Study Comparing Effectiveness of Intraperitoneal Insulin Administration to Subcutaneous Insulin Administration#356621ClinicalTrials.gov
• (D161A)MamK-GFP/wild type#366468CaltechDATA
• Hypoglycemia Prediction in Type 1 Diabetes With Electrocardiography Beat Ensembles#372149PubMed Central
• Type Ia supernova feedback effects on globular clusters of different masses#398755HAL (France)
• GLP-1/Basal Insulin Combination Therapy#417471ClinicalTrials.gov
• Selecting Insulin Analogs for Closed-Loop Control Using Multiplex Pharmacokinetic Profiling#429701ClinicalTrials.gov
• Study to Assess the Metabolic Impact of IRTA© and Patients Satisfaction in Type 1 Diabetic Patients, Treated by Either Insulin Pump or Multiple Daily Insulin Injections, and Using Freestyle Libre®, a Real-time Continuous Glucose Monitoring#238279ClinicalTrials.gov
• Association Between the Tissue and Circulating Advanced Glycation End-Products and the Micro- and Macrovascular Complications in Type 1 Diabetes: The DIABAGE Study#424869HAL (France)
• Efficacy/Safety Study of Amaryl®M 1/500 mg Twice Daily Versus Amaryl® 4 mg Both in Combination With Lantus® in Type 2 Diabetes Mellitus#356638ClinicalTrials.gov
• Real-world Evaluation of GLP-1 Receptor Agonists (GLP-1RA) on Efficacy and Persistence, Adherence and Therapeutic Inertia Among Type 2 Diabetes Adults With Obesity#366569ClinicalTrials.gov
• Preadmission GLP-1 Receptor Agonist Plus SGLT2 Inhibitor Use and Early Outcomes After Pneumonia Hospitalization in Adults With Type 2 Diabetes#426752ClinicalTrials.gov
• Leukocyte Telomere Length, DNA Oxidation, and Risk of Lower-Extremity Amputation in Patients With Long-standing Type 1 Diabetes#408714HAL (France)
• Causal Mediation Pathways in Continuous Postprandial Glucose Monitoring for Type 1 Diabetes Patients#13882bioRxiv / medRxiv
• Desensitization for Highly Sensitized Recipients of Pancreas Transplantation#121242ClinicalTrials.gov
• Islet Transplantation in Type 1 Diabetic Recipients of Kidney Transplants#126026ClinicalTrials.gov
• Urging increased Federal funding for juvenile (Type 1) diabetes research.#128862Congress.gov
• Management of Prolonged Aerobic exeRcise in Patients With Type 1 Diabetes on Advanced Technologies#152570ClinicalTrials.gov
• Diabetes Technologies in Ultra-Endurance Type 1 Diabetes: Qualitative Study.#165866NCBI PubMed Central
• Autologous Adoptive T Regulatory Cell Transfer in Autoimmune Diseases.#171295ClinicalTrials.gov
• GLP-1-mediated Gluco-metabolic Effects of Bile Acid Sequestration#184803ClinicalTrials.gov
• Type 1 Diabetes Polygenic Scores Improve Diagnostic Accuracy in Pediatric Diabetes Care.#209464NCBI PubMed Central
• Mindfulness-Based Intervention for Adolescents With Type 1 Diabetes: A Case Series.#247492NCBI PubMed Central
• Efficacy of Hyperbaric Oxygen Therapy (HBOT) in New-onset Type-1 Diabetes Mellitus#249533ClinicalTrials.gov
• Exercise-induced Glycemic Variations and Hybrid Closed-loop Systems#279653ClinicalTrials.gov
• Weight Gain After Smoking Cessation and NAFLD#287459ClinicalTrials.gov
• Sugar slay: a gamified decision support ecosystem for type 1 diabetes.#334570NCBI PubMed Central